Logo

Massive Bio Drug Matching Software

Jan 04, 2023

Massive Bio has announced plans to introduce an artificial intelligence-powered drug matching software product in the first half of 2023. The unnamed product, which will be targeted toward oncologists, biotech, and pharmaceutical companies, will build on the the company's Synergy-AI global registry for clinical trial matching, which now counts more than 100,000 enrollees. It will also complement the 100K Cancer Clinical Trial Singularity Program, Massive Bio's ambitious plan to apply AI to improve clinical trial matching for cancer patients.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.